Bio-Rad Laboratories (BIO) Receivables - Other (2019 - 2025)
Bio-Rad Laboratories (BIO) has disclosed Receivables - Other for 7 consecutive years, with $11.9 million as the latest value for Q4 2025.
- On a quarterly basis, Receivables - Other fell 9.16% to $11.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $11.9 million, a 9.16% decrease, with the full-year FY2025 number at $11.9 million, down 9.16% from a year prior.
- Receivables - Other was $11.9 million for Q4 2025 at Bio-Rad Laboratories, up from $9.5 million in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $14.8 million in Q1 2023 to a low of $1.4 million in Q1 2021.
- A 5-year average of $9.0 million and a median of $9.6 million in 2024 define the central range for Receivables - Other.
- Peak YoY movement for Receivables - Other: dropped 26.32% in 2021, then surged 427.27% in 2022.
- Bio-Rad Laboratories' Receivables - Other stood at $2.2 million in 2021, then soared by 427.27% to $11.6 million in 2022, then grew by 2.59% to $11.9 million in 2023, then grew by 10.08% to $13.1 million in 2024, then decreased by 9.16% to $11.9 million in 2025.
- Per Business Quant, the three most recent readings for BIO's Receivables - Other are $11.9 million (Q4 2025), $9.5 million (Q3 2025), and $8.1 million (Q2 2025).